There has been limited research into the value of the FIT beyond its primary use as an adjunct for referral or investigation of suspected CRC (e.g., if there is a correlation between faecal haemoglobin concentration [f‐Hb] and tumour features). The gene discussed is GSTM1; the disease is neoplasm.